Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avalon Globocare (NQ: AVCO )

0.4558 +0.0058 (+1.29%)
Streaming Delayed Price Updated: 11:40 AM EDT, May 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Avalon Globocare

< Previous 1 2 Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million. 
Via Benzinga
NASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities and Cellular Therapy Developers; Avalon Globocare Corp. (NASDAQ: AVCO)
Via Viz Release
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
NASDAQ Roundtable: $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies and Therapeutics be next? Avalon Globocare Corp.  (NASDAQ: AVCO)
Via Viz Release
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers NexImmune (NASDAQ:NEXI) stock moved upwards by 8.3% to $3.51 during Monday's after-market session. This security traded at a volume of 109.1K shares come close, making up 76.6% of its average... 
Via Benzinga
NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)
Via Viz Release
Cell-based Technologies and Therapeutics Global Developer Expands its Immuno-Oncology (mRNA)-based Platform. IND Application on the Horizon for this rising NASDAQ Company: Avalon Globocare Corp (NASDAQ: AVCO)
Via Viz Release
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares increased by 27.8% to $1.77 during Friday's regular session. The current volume of 149.1K shares is 551.4% of... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Unicycive Therapeutics (NASDAQ:UNCY 
Via Benzinga
Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.
Via Viz Release
Avalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
Avalon GloboCare Corp (NASDAQ: AVCO) is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-... 
Via Benzinga
Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.
Via Viz Release
Avalon Globocare Corps (NASDAQ: AVCO) Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients. AVCO could be the next big Biotech
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
NASDAQ Company offers Life Saving Medical Advances; AI and Immunotherapy for Cancer and Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Year End Update for this Up and Coming NASDAQ at the forefront of innovations in healthcare Featuring AI and Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is AVCO the Next BFRI?
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
NASDAQ at the forefront of innovations in healthcare. Avalon GloboCare Corp. (NASDAQ:AVCO): AVCO's Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
Via Viz Release
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Eloxx Pharmaceuticals (NASDAQ: 
Via Benzinga
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO),  Palantir Technologies (NYSE: PLTR) and Nvidia (NVDA) lead the Charge and Artificial Intelligence (AI) is at the forefront of innovations in healthcare.
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Applied DNA Sciences (NASDAQ:APDN... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion.... 
Via Benzinga
20 Stocks Moving in Monday's Pre-Market Session
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... 
Via Benzinga
This NASDAQ has Life Saving Advances in Today's Most Critical Bio-Science Fields of Cancer and Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
Via Viz Release
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Vaxart (NASDAQ:VXRT) shares incr... 
Via Benzinga
Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
Image Provided by Pixabay Cytokine storm has made frequent appearances in the news lately as a life-threatening complication in patients suffering from COVID-19. The condition is... 
Via Benzinga
Exposures COVID-19
Avalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T Treatment
Image Provided by Pexels With a compound annual growth rate (CAGR) of 34.2%, the global CAR-T cell therapy market is projected to hit $15.4 billion by 2028. This hypergrowth is... 
Via Benzinga
Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers INmune Bio (NASDAQ:INMB) shares ... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.